Partners Capital Investment Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-170,043
| Closed | -$26.6M | – | 157 |
|
|
2020
Q4 | $26.6M | Buy |
170,043
+4,577
| +3% | +$715K | 1.52% | 21 |
|
|
2020
Q3 | $18.9M | Buy |
165,466
+25,476
| +18% | +$2.92M | 1.17% | 29 |
|
|
2020
Q2 | $15.7M | Buy |
139,990
+36,303
| +35% | +$4.07M | 0.77% | 36 |
|
|
2020
Q1 | $9.31M | Buy |
103,687
+30,251
| +41% | +$2.72M | 0.64% | 39 |
|
|
2019
Q4 | $7.94M | Buy |
73,436
+1,828
| +3% | +$198K | 0.6% | 46 |
|
|
2019
Q3 | $7.01M | Buy |
71,608
+19,728
| +38% | +$1.93M | 0.61% | 48 |
|
|
2019
Q2 | $6.8M | Buy |
51,880
+4,451
| +9% | +$583K | 0.68% | 46 |
|
|
2019
Q1 | $6.41M | Buy |
47,429
+5,402
| +13% | +$730K | 0.63% | 41 |
|
|
2018
Q4 | $4.09M | Buy |
42,027
+13,790
| +49% | +$1.34M | 0.49% | 52 |
|
|
2018
Q3 | $3.93M | Buy |
28,237
+3,644
| +15% | +$507K | 0.42% | 47 |
|
|
2018
Q2 | $3.05M | Buy |
24,593
+5,099
| +26% | +$633K | 0.39% | 49 |
|
|
2018
Q1 | $2.17M | Buy |
19,494
+10,661
| +121% | +$1.19M | 0.29% | 52 |
|
|
2017
Q4 | $1.06M | Buy |
8,833
+4,400
| +99% | +$526K | 0.17% | 51 |
|
|
2017
Q3 | $622K | Buy |
+4,433
| New | +$622K | 0.1% | 45 |
|